Free Trial

Apollomics (APLMW) Competitors

Apollomics logo
$0.02 0.00 (-13.04%)
As of 03:28 PM Eastern

APLMW vs. SXTPW, DRTSW, BIVIW, CDIOW, and CELUW

Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BioVie (BIVIW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does Apollomics compare to 60 Degrees Pharmaceuticals?

Apollomics (NASDAQ:APLMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
60 Degrees Pharmaceuticals Neutral

Summary

Apollomics beats 60 Degrees Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does Apollomics compare to Alpha Tau Medical?

Apollomics (NASDAQ:APLMW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Alpha Tau Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Summary

Apollomics beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does Apollomics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, BioVie's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats BioVie on 1 of the 1 factors compared between the two stocks.

How does Apollomics compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.83KN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does Apollomics compare to Celularity?

Apollomics (NASDAQ:APLMW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Celularity Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Summary

Celularity beats Apollomics on 1 of the 1 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLMW vs. The Competition

MetricApollomicsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$446.03M$6.24B$11.86B
Dividend YieldN/A3.86%2.73%5.21%
P/E RatioN/A4.1929.0428.48
Price / SalesN/A6,879.71477.1060.43
Price / CashN/A13.1327.6236.52
Price / BookN/A77.749.676.67
Net IncomeN/A-$96.07M$3.55B$332.64M
7 Day PerformanceN/A0.71%1.70%2.01%
1 Month PerformanceN/A3.87%5.62%9.19%
1 Year PerformanceN/A48.54%34.42%39.59%

Apollomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLMW
Apollomics
N/A$0.02
-13.0%
N/AN/A$0.00$8.50MN/A59
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-0.4%
N/AN/A$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$1.08
-18.8%
N/AN/A$0.00N/AN/A80
BIVIW
BioVie
N/A$0.32
-8.5%
N/AN/A$0.00N/AN/AN/A
CDIOW
Cardio Diagnostics
N/A$0.02
+26.4%
N/AN/A$0.00$14.83KN/A7

Related Companies and Tools


This page (NASDAQ:APLMW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners